Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $3.25 $4.30 Thursday, 9th May 2024 GERN stock ended at $3.88. This is 1.84% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 3.16% from a day low at $3.80 to a day high of $3.92.
90 days $1.64 $4.30
52 weeks $1.64 $4.30

Historical Geron Corporation prices

Date Open High Low Close Volume
Sep 15, 2016 $2.06 $2.11 $1.94 $1.97 3 928 600
Sep 14, 2016 $2.18 $2.24 $2.02 $2.07 4 891 200
Sep 13, 2016 $2.23 $2.29 $2.11 $2.17 4 195 300
Sep 12, 2016 $2.12 $2.45 $2.06 $2.30 12 942 300
Sep 09, 2016 $3.10 $3.10 $2.86 $2.86 2 945 600
Sep 08, 2016 $3.03 $3.09 $3.03 $3.05 1 415 100
Sep 07, 2016 $3.04 $3.13 $3.02 $3.05 2 008 900
Sep 06, 2016 $2.75 $3.04 $2.72 $3.02 3 723 000
Sep 02, 2016 $2.75 $2.78 $2.69 $2.75 996 500
Sep 01, 2016 $2.68 $2.73 $2.66 $2.73 847 100
Aug 31, 2016 $2.68 $2.72 $2.64 $2.69 1 284 200
Aug 30, 2016 $2.65 $2.70 $2.63 $2.69 1 090 700
Aug 29, 2016 $2.70 $2.70 $2.64 $2.66 873 700
Aug 26, 2016 $2.67 $2.76 $2.65 $2.70 1 260 400
Aug 25, 2016 $2.67 $2.73 $2.61 $2.67 1 152 800
Aug 24, 2016 $2.72 $2.80 $2.65 $2.65 2 263 500
Aug 23, 2016 $2.77 $2.77 $2.71 $2.73 662 800
Aug 22, 2016 $2.71 $2.74 $2.69 $2.74 933 500
Aug 19, 2016 $2.71 $2.75 $2.70 $2.72 780 900
Aug 18, 2016 $2.73 $2.76 $2.68 $2.73 723 800
Aug 17, 2016 $2.74 $2.76 $2.70 $2.73 758 000
Aug 16, 2016 $2.87 $2.87 $2.74 $2.74 1 389 500
Aug 15, 2016 $2.75 $2.87 $2.72 $2.87 2 013 200
Aug 12, 2016 $2.69 $2.75 $2.67 $2.74 671 600
Aug 11, 2016 $2.66 $2.72 $2.63 $2.70 780 200
Click to get the best stock tips daily for free!

About Geron Corporation

Geron Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hematologic myeloid malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes a... GERN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT